English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/3392
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau

AuthorsSanta María, Ismael ; Hernández Pérez, Félix ; Río, Joaquín del; Moreno Muñoz, Francisco José; Ávila, Jesús
Issue Date6-Sep-2007
PublisherBioMed Central
CitationMol Neurodegener. 2007; 2: 17
AbstractAlzheimer's disease (AD) is characterized by the presence of two histopathological hallmarks; the senile plaques, or extracellular deposits mainly composed of amyloid-β peptide (Aβ), and the neurofibrillary tangles, or intraneuronal inclusions composed of hyperphosphorylated tau protein. Since Aβ aggregates are found in the pathological cases, several strategies are under way to develop drugs that interact with Aβ to reduce its assembly. One of them is 3-amino-1-propane sulfonic acid (Tramiprosate, 3-APS, Alzhemed™), that was developed as a sulfated glycosaminoglycan mimetic, that could interact with Aβ peptide, preventing its aggregation. However, little is known about the action of 3-APS on tau protein aggregation. In this work, we have tested the action of 3-APS on cell viability, microtubule network, actin organization and tau aggregation. Our results indicate that 3-APS favours tau aggregation, in tau transfected non-neuronal cells, and in neuronal cells. We also found that 3-APS does not affect the binding of tau to microtubules but may prevent the formation of tau-actin aggregates. We like to emphasize the importance of testing on both types of pathology (amyloid and tau) the potential drugs to be used for AD treatment.
DescriptionThis article is available from: http://www.molecularneurodegeneration.com/content/2/1/17
URIhttp://hdl.handle.net/10261/3392
DOI10.1186/1750-1326-2-17
ISSN1750-1326
Appears in Collections:(CBM) Artículos
Files in This Item:
File Description SizeFormat 
picrender.pdfPrincipal684,34 kBAdobe PDFThumbnail
View/Open
1750-1326-2-17-S1.pdfArchivo adicional 1415,12 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.